Us Congress 2023-2024 Regular Session

Us Congress House Bill HR1505

Introduced
9/25/24  

Caption

Expressing support for the designation of September 2024 as "National Polycystic Kidney Disease Awareness Month", and raising awareness and understanding of polycystic kidney disease.

Impact

The recognition of National Polycystic Kidney Disease Awareness Month serves to amplify awareness and understanding of PKD's effects beyond the immediate health ramifications, extending to financial and emotional stressors faced by individuals and their caregivers. By fostering broader public awareness, the resolution aims to encourage more individuals to seek regular healthcare, potentially leading to earlier diagnosis and management of PKD symptoms, thereby reducing complications such as kidney failure, which afflicts nearly half of those diagnosed by age 60.

Summary

HR1505 is a resolution proposing the designation of September 2024 as 'National Polycystic Kidney Disease Awareness Month'. This initiative aims to enhance public awareness and understanding of polycystic kidney disease (PKD), a prevalent genetic disorder affecting approximately 500,000 individuals in the United States. The resolution not only acknowledges the impacts of PKD on patients and families but also highlights the necessity for further research into treatment options and cures for this serious health condition.

Contention

While the bill has general support due to its focus on raising awareness for a condition that is often overlooked, some criticism may arise regarding the effectiveness of awareness months in making tangible changes. Critics might argue that while awareness is beneficial, it should be accompanied by concrete policy changes or funding initiatives to support research and treatment accessibility for those affected by PKD. The alignment of public health awareness with actionable public health strategies will be a topic of discussion among stakeholders.

Companion Bills

No companion bills found.

Previously Filed As

US HR1384

Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2024 as "PCOS Awareness Month".

US HR678

Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2023 as "PCOS Awareness Month".

US HR175

Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September as "PCOS Awareness Month".

US HR1257

Expressing the need for enhanced public awareness of Huntington's Disease and support for the designation of a "National Huntington's Disease Awareness Month".

US SR384

A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2023 as "PCOS Awareness Month".

US HR728

Expressing support for the designation of September 2023 as "Peripheral Artery Disease Awareness Month".

US HR1508

Supporting the designation of September 2024 as "National Ovarian Cancer Awareness Month".

US HR360

Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day".

US HR700

Expressing support for the designation of September 2023 as "National Prostate Cancer Awareness Month".

US HR1426

Expressing support for the designation of September 2024 as National Campus Sexual Assault Awareness Month.

Similar Bills

NH HB33

Relative to polycystic ovary syndrome awareness.

SC S0535

Declare September as PCOS Awareness Month

SC H4308

Declare September as PCOS Awareness Month

NC H749

Study Polycystic Ovary Syndrome

VA HB604

Health insurance; coverage for polycystic ovary syndrome.

IN SR0040

Recognizing the National Polycystic Ovary Syndrome Association's PCOS Challenge.

NJ A3366

Establishes Women's Menstrual Health Program to identify and assist patients with symptoms related to endometriosis and polycystic ovary syndrome.

NJ S2244

Establishes a Women's Menstrual Health Screening Program and requirements to screen appropriate patients for endometriosis and polycystic ovary syndrome.